Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Osteoclast stimulating factor 1 is a protein produced by the OSTF1 gene, located on chromosome 9. It promotes bone resorption and influences osteoclast formation through intracellular signaling, cytoskeletal reorganization, and protein-protein interactions. OSTF1 contains an SH3 domain and ankyrin repeats, and it is found in the cytosol, nucleus, and Golgi apparatus. OSTF1 interacts with several proteins, including c-Src, Cbl, myosin 1E, and SMN1/2, influencing bone development, cell motility, chromatin remodeling, and RNA splicing. Mutations or deletions of OSTF1 are associated with a spectrum of bone and retinal diseases, as well as developmental syndromes. There are currently no approved drugs that specifically target OSTF1. Interventions affecting OSTF1 could have substantial effects on bone density and developmental outcomes.
Not applicable; no drugs explicitly target OSTF1 per current literature. Its role is intracellular modulation of bone resorption and signaling rather than being a drug target itself
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Osteoclast stimulating factor 1 (OSTF1).